Template:Pico of the day

From Wiki Journal Club
Jump to: navigation, search
Clinical question of the day
In patients 70 years or younger with chronic lymphocytic leukemia (CLL), how does the safety and efficacy of ibrutinib-rituximab compare to the chemoimmunotherapy regimen of fludarabine-cyclophosphamide-rituxmiab?